Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment (Q41288216)
scientific article
Language:
Current Data About Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment
(P31) (Q13442814)
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(P50) (Q29643352)
(P1545) 1
(P1932) R M Norris
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(Q1587897)
(P1545) 2
(P1932) H D White
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(P304) 104-106
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(P407) (Q1860)

(P433) 8577
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(P478) 1
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(P577) Friday, January 1, 1988
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(P921) (Q261327)

(Q707774)
(P887)

(P1433) (Q939416)
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

(P1476) "Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment" (language: en)
(P248)
(P698) 2891942
(P813) Friday, September 29, 2017

other details
description scientific article

External Links
(P356) 10.1016/S0140-6736(88)90295-4
(P698) 2891942